Literature DB >> 15184289

Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support.

Pier D Lambiase1, Richard J Edwards, Prodromos Anthopoulos, Salman Rahman, Y Gloria Meng, Clifford A Bucknall, Simon R Redwood, Jeremy D Pearson, Michael S Marber.   

Abstract

BACKGROUND: The mechanisms underlying the variation in collateral formation between patients, even with similar patterns of coronary artery disease, remain unclear. This study investigates whether circulating humoral or cellular factors can provide an insight into this variation. METHODS AND
RESULTS: Thirty patients with isolated left anterior descending coronary artery disease underwent percutaneous coronary intervention with collateral flow index (CFI) determined using a pressure wire. Patients with inadequate (CFI <0.25) compared with those with adequate (CFI > or =0.25) collateral support had, or tended to have, lower concentrations of coronary sinus growth factors and plasma exerting a weaker effect on endothelial cell migration and angiogenesis in vitro. However, there was an inverse correlation between serum mitogenicity and CFI (r=-0.61, P<0.01). No significant differences were detected between the 2 groups in plasma levels of total vascular endothelial growth factor, vascular endothelial growth factor165, or placental growth factor. There was a strong positive correlation between numbers of CD34/CD133-positive circulating hemopoietic precursor cells and CFI (r=0.75, P<0.001). In patients with inadequate, compared with those with adequate, CFI, the numbers of differentiated endothelial progenitor cells (EPCs) appearing in the circulation and in culture were significantly reduced by 75% (P<0.05) and 70% (P<0.05), respectively.
CONCLUSIONS: In this study, inadequate coronary collateral development is associated with reduced numbers of circulating EPCs and impaired chemotactic and proangiogenic but not mitogenic activity. These findings are consistent with current efforts to enhance collateral formation by augmentation of circulating EPCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184289     DOI: 10.1161/01.CIR.0000130639.97284.EC

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  30 in total

1.  Enhancement of In Vitro Capillary Tube Formation by Substrate Nanotopography.

Authors:  Christopher J Bettinger; Zhitong Zhang; Sharon Gerecht; Jeffrey T Borenstein; Robert Langer
Journal:  Adv Mater       Date:  2008       Impact factor: 30.849

2.  Regulation of endothelial progenitor cell release by Wnt signaling in bone marrow.

Authors:  Xiaochen Liu; Jeffrey McBride; Yueping Zhou; Zuguo Liu; Jian-Xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-11       Impact factor: 4.799

3.  MicroRNA-423 may regulate diabetic vasculopathy.

Authors:  Arnon Blum; Ari Meerson; Hanan Rohana; Hanin Jabaly; Nahul Nahul; Dorina Celesh; Olga Romanenko; Snait Tamir
Journal:  Clin Exp Med       Date:  2019-08-17       Impact factor: 3.984

Review 4.  Immune system in renal injury and repair: burning the candle from both ends?

Authors:  Michael S Goligorsky
Journal:  Pharmacol Res       Date:  2008-06-08       Impact factor: 7.658

Review 5.  Delivery of large biopharmaceuticals from cardiovascular stents: a review.

Authors:  Hironobu Takahashi; Didier Letourneur; David W Grainger
Journal:  Biomacromolecules       Date:  2007-10-12       Impact factor: 6.988

6.  Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease.

Authors:  Yen-Ta Chen; Ben-Chung Cheng; Sheung-Fat Ko; Chih-Hung Chen; Tzu-Hsien Tsai; Steve Leu; Hsueh-Wen Chang; Sheng-Ying Chung; Sarah Chua; Kuo-Ho Yeh; Yung-Lung Chen; Hon-Kan Yip
Journal:  Clin Exp Nephrol       Date:  2012-07-20       Impact factor: 2.801

7.  Evaluation of late outgrowth endothelial progenitor cell and umbilical vein endothelial cell responses to thromboresistant collagen-mimetic hydrogels.

Authors:  Dany J Munoz-Pinto; Josh D Erndt-Marino; Silvia M Becerra-Bayona; Viviana R Guiza-Arguello; Satyavrata Samavedi; Sarah Malmut; William M Reichert; Brooke Russell; Magnus Höök; Mariah S Hahn
Journal:  J Biomed Mater Res A       Date:  2017-03-29       Impact factor: 4.396

8.  Vascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy.

Authors:  Adriana Georgescu
Journal:  World J Diabetes       Date:  2011-06-15

Review 9.  Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation.

Authors:  Jörn Tongers; Jerome G Roncalli; Douglas W Losordo
Journal:  Microvasc Res       Date:  2010-02-06       Impact factor: 3.514

Review 10.  Review article: endothelial progenitor cells in renal disease.

Authors:  Michael S Goligorsky; Mei-Chuan Kuo; Daniel Patschan; Marianne C Verhaar
Journal:  Nephrology (Carlton)       Date:  2009-04       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.